Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Timothy Springer

Timothy Springer

Timothy Springer (#1769)

Global Rank #1769
Country Rank #624
Country United States

Timothy Springer is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 2 B
  • Biotech
  • United States
  • M
  • 78 Years

Snapshot

Quick Facts

Global Rank #1,769
Country Rank #624
Net Worth $2.3B
Previous Worth $2.2B
Worth Change +$0.1B
Country United States
Industry Biotech
Age 78 Years
Gender M
Worth As Of May 5, 2026
Last Refreshed 17 Sep 2026, 12:00 AM
Residence Chestnut Hill, Massachusetts
World Billionaires List United States Billionaires Biotech

Profile Data

Personal Stats

Age 78
Source Of Wealth Biotech, Self Made
Self Made Score 8
Philanthropy Score 1
Residence Chestnut Hill, Massachusetts
Citizenship United States
Marital Status Married
Education Bachelor of Science, University of California, Berkeley; Ph.D, Harvard University
Net Worth Change +$0.1B +4.5% from previous worth
Previous Net Worth $2.2B
Current Net Worth $2.3B

Worth as of May 5, 2026

About Me

Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School. He was a founding investor in publicly traded biotech outfit Moderna, investing about $5 million in 2010; he now owns an estimated 3% of the firm's shares. Springer also owns shares of three smaller publicly traded biotech firms: Cartesian Therapeutics, Scholar Rock and Tectonic Therapeutic. He first started teaching at Harvard in 1977 as an assistant professor. In 1993, he founded biotech firm LeukoSite and took it public in 1998; the next year, he sold it to Millennium Therapeutics for $635 million.

Insights

Did You Know?

In 2017, Springer established the Institute for Protein Innovation, an independent nonprofit focused on researching proteins, with an initial grant of $10 million.

Springer bikes to work from his home in Chestnut Hill, Massachusetts.

Wealth Growth

Net Worth Growth Over Time

Tracking Timothy Springer's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $2.3B (May 5, 2026)

© Iconic Billionaires